| ID | 117184 |
| Author |
Okada, M
Sakamoto Hospital
Bando, Hiroshi
Sakamoto Hospital|Tokushima University|Japan Low Carbohydrate Diet Promotion Association
KAKEN Search Researchers
Iwatsuki, N
Sakamoto Hospital
Ogawa, T
Sakamoto Hospital
Sakamoto, K
Sakamoto Hospital
|
| Keywords | Oral semaglutide
Imeglimin
Twymeeg
Macrocytic anemia
Trial for Imeglimin Efficacy and Safety (TIMES)
|
| Content Type |
Journal Article
|
| Description | Background: Oral semaglutide (imeglimin) has been prescribed for patients with type 2 diabetes (T2D) as Twymeeg.
Case presentation: The patient is 77-year-old male with hypertension, previous cerebral vascular accident (CVA). He continued unbalanced meal with preference of much carbohydrate. In Sept 2021, he became diabetic with HbA1c 8.8%. Results: Imeglimin 2000mg/day was started improving to 6.7% for 2 months. Discussion: Complete blood count (CBC) showed decreased Hb and increased MCV, suggesting macrocytic anemia for lack of vegetables. Much carbohydrate intake may bring T2D. Remarkable diabetic improvement may be from dual mechanisms for increasing insulin secretion and decreasing insulin resistance. |
| Journal Title |
SunText Review of Medical & Clinical Research
|
| ISSN | 27664813
|
| Publisher | SunText Reviews
|
| Volume | 3
|
| Issue | 2
|
| Start Page | 155
|
| Published Date | 2022-05-12
|
| Rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
|
| DOI (Published Version) | |
| URL ( Publisher's Version ) | |
| FullText File | |
| language |
eng
|
| TextVersion |
Publisher
|
| departments |
Medical Sciences
|
